AEON vs DOW · P/E 0.0, $8.6M cap vs P/E 74, rev $39.97B
AEON Biopharma, Inc. (AEON) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
AEON does not have a complete income-statement cache yet.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the AEON and DOW stock pages for the full models.
Not investment advice.